Posttransplant medical complications

The Surgical Clinics of North America
V K Rao

Abstract

A variety of medical, surgical, social, and psychiatric problems affect the renal allograft rejection, thromboembolic disease, infectious events and gastrointestinal disorders. Hypertension and hyperlipidemia appear around 3 months and may remain throughout the posttransplant period. The late complication are atherosclerotic cardiovascular disease, malignancy hepatic failure, chronic rejection, denovo and recurrent renal disease, posttransplant diabetes, musculoskeletal problems, cataracts and skin lesions. Routine follow up of all transplanted patients at specialized centers is critical for early detection and management of these complications. Such practice would reduce the patient morbidity and mortality and lead to an improved long-term outcome.

References

Oct 1, 1976·Archives of Surgery·K VenkateswaraV E Pollack
Jan 1, 1992·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·A T WebbE A Brown
May 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·K V Rao, W R Anderson
Dec 1, 1991·American Journal of Surgery·J ReeseP Garvin
Sep 1, 1991·Transplantation·N L TilneyD H Adams
Feb 1, 1992·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·B A JulianK M Niemann
Jan 1, 1991·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·T DasK S Chugh
Aug 1, 1991·Transplantation·F M ModenaM E Rosenberg
Feb 1, 1991·Transplantation·B L KasiskeK V Rao
Jun 1, 1991·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·B L KasiskeK V Rao
Mar 1, 1991·Journal of the American Academy of Dermatology·G Lugo-JanerE Santiago-Delpin
Jan 1, 1990·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·S FrimanI Blohmé
Oct 1, 1990·Transplant International : Official Journal of the European Society for Organ Transplantation·G BenoitD Fries
Sep 1, 1990·American Journal of Hypertension·D A Laskow, J J Curtis
Mar 1, 1988·Ultrastructural Pathology·P F ZhangW R Anderson
Sep 1, 1985·Mayo Clinic Proceedings·J A VelosaK P Offord
Jan 1, 1983·Clinical and Experimental Dialysis and Apheresis·K V Rao, C M Kjellstrand
Mar 1, 1984·Transplantation·A HendrickW M O'Neill
Jun 27, 1995·Transplantation·S B GayaP D Mason
Jan 1, 1995·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·A M Davison

❮ Previous
Next ❯

Citations

Nov 13, 2003·Transplantation Proceedings·F N OzdemirM Haberal
Mar 26, 2004·Transplantation Proceedings·M HaberalN Bilgin
Sep 25, 2002·Transplantation Proceedings·A StephanA Masri
Aug 17, 2000·Clinical Transplantation·M A ChisholmJ T DiPiro
Aug 12, 2000·Acta Anaesthesiologica Scandinavica·H J Toivonen
Jul 5, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Iman O HypoliteKevin C Abbott
Nov 2, 2001·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·T M McCashland
Dec 26, 2001·Current Opinion in Nephrology and Hypertension·Giuseppe Remuzzi, Norberto Perico
Jul 5, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·B Fellström
Jun 30, 2005·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Hallvard Holdaas
May 26, 2007·Transplantation Proceedings·M-T HollisaazM Ebrahiminia
Oct 3, 2002·The American Journal of Gastroenterology·Rafael AmaroJeffrey B Raskin
Oct 26, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·R MooreH Valantine
Mar 9, 2011·Transplant International : Official Journal of the European Society for Organ Transplantation·Claudio PonticelliGiorgio Graziani
Mar 7, 2000·Journal of the American Society of Nephrology : JASN·John R Silkensen
Jun 28, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Carlos A Aguilar-SalinasRicardo Correa-Rotter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.